SuperX
  1. Home
  2. Stocks
  3. BFBIO
  4. Financials

BFBIO · PHARMACEUTICALS

BFBIO financials BF Biosciences Limited

BF Biosciences Limited (BFBIO) has 2 financial years on file, from the year to 30 Jun 2025. The latest, the year to 30 Jun 2026 earned Rs 7.16 a share on sales of Rs 9.5 bn. 5 quarters are listed below the years.

Results by financial year

Company accounts as filed. Earnings per share are on today’s share count where a split or bonus issue came later. Years to 30 June. 2 of the last 5 years and 5 of the last 8 quarters.

Earnings per share by financial year

Rupees a share, by year to the month shown. Source: the company's filed accounts, latest year to 30 Jun 2026.
YearEarnings per share (Rs)SalesGross marginNet profit as a share of salesChange in earnings per share on the year before
Year to 30 Jun 20267.16Rs 9.5 bn43.2%6.7%+29.7%
Year to 30 Jun 20255.52Rs 5.8 bn39.2%7.7%—

Results by quarter

5 of the last 8 quarters. The fourth quarter is filed only inside the annual accounts.

QuarterEarnings per share (Rs)SalesProfit after taxNet profit as a share of salesChange on the same quarter a year before
Quarter to 30 Sep 20262.09Rs 2.8 bnRs 184.9 m6.6%+15.5%
Quarter to 31 Mar 20261.33Rs 2.1 bnRs 117.6 m5.5%-16.4%
Quarter to 31 Dec 20252.13Rs 2.7 bnRs 187.8 m7.0%—
Quarter to 30 Sep 20251.81Rs 2.4 bnRs 159.5 m6.6%—
Quarter to 31 Mar 20251.59Rs 1.5 bnRs 124.5 m8.3%—

Annual report figures: income and balance sheet

From each annual report. A blank is a line this page does not show for that year.

YearRevenueGross profitProfit after taxTotal assetsEquityLiabilitiesReturn on equityCurrent ratioBasis
Year to 30 Jun 2026Rs 9.5 bnRs 4.1 bnRs 632.1 m—————unknown
Year to 30 Jun 2025Rs 5.8 bnRs 2.3 bnRs 447.1 m—————unknown

Source: the company’s annual reports.

Cash flow

Where the cash came from and went

Profit after taxRs 632.1 m
Depreciation and amortisationRs 0 thousand
Operating cash flow−Rs 26.5 m
Capital spending−Rs 603.1 m
Free cashworked out: operating cash flow less capital spending−Rs 629.6 m
Change in cash−Rs 73.1 m
Cash at the start of the yearRs 322.4 m
Cash at the end of the yearRs 249.3 m

Accounts, year to 30 Jun 2026 · filed annual report, page 61The report does not say whether these are group accounts or the company’s own.

Debt

Borrowings and cash

Interest covered by operating profit: Rs 1.2 bn against Rs 106.0 m, 11.1 times

Accounts, year to 30 Jun 2026 · filed annual report, page 61The report does not say whether these are group accounts or the company’s own.

More on BFBIO

Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .